ロード中...
Trial participation disclosure and gel use behavior in the CAPRISA 004 tenofovir gel trial
Disclosure, or open communication, by female microbicide trial participants of their trial participation and use of an investigational HIV prevention drug to a sexual partner may affect participants' trial product usage behavior and contribute to poor adherence. With mixed results from recent m...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Routledge
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4193265/ https://ncbi.nlm.nih.gov/pubmed/25285564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/09540121.2014.938014 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|